These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18720237)

  • 1. Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.
    Wang G; Fiske JD; Jennings SP; Tomasella FP; Palaniswamy VA; Ray KL
    Pharm Dev Technol; 2008; 13(5):393-9. PubMed ID: 18720237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
    Nassar MN; Nesarikar VN; Lozano R; Parker WL; Huang Y; Palaniswamy V; Xu W; Khaselev N
    Pharm Dev Technol; 2004; 9(2):189-95. PubMed ID: 15202578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
    Mehta S; Shah RP; Priyadarshi R; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of degradation products of irbesartan using LC-MS/TOF, MS(n), on-line H/D exchange and LC-NMR.
    Shah RP; Sahu A; Singh S
    J Pharm Biomed Anal; 2010 Apr; 51(5):1037-46. PubMed ID: 20018473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.
    Fujita M; Ueda T; Iwata M
    Int J Pharm; 2010 Feb; 386(1-2):195-200. PubMed ID: 19931605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution degradant of mirabegron extended release tablets resulting from a Strecker-like reaction between mirabegron, minute amounts of hydrogen cyanide in acetonitrile, and formaldehyde in PEG during sample preparation.
    Lin J; Huang T; Feng M; Li D; Zhao D; Wang J; Jin J; Zhu W; Li M
    J Pharm Biomed Anal; 2019 May; 168():181-188. PubMed ID: 30818256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures.
    Nassar MN; Nesarikar VV; Lozano R; Huang Y; Palaniswamy V
    Pharm Dev Technol; 2005; 10(2):227-32. PubMed ID: 15926671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400.
    Bindra DS; Williams TD; Stella VJ
    Pharm Res; 1994 Jul; 11(7):1060-4. PubMed ID: 7937549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS screening techniques for wastewater analysis and analytical data handling strategies: Sartans and their transformation products as an example.
    Letzel T; Bayer A; Schulz W; Heermann A; Lucke T; Greco G; Grosse S; Schüssler W; Sengl M; Letzel M
    Chemosphere; 2015 Oct; 137():198-206. PubMed ID: 26246044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standard.
    Prasaja B; Sasongko L; Harahap Y; Hardiyanti ; Lusthom W; Grigg M
    J Pharm Biomed Anal; 2009 Apr; 49(3):862-7. PubMed ID: 19217738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure elucidation and formation mechanistic study of a methylene-bridged pregabalin dimeric degradant in pregabalin extended-release tablets.
    Tian Y; Lin J; Chen F; Wang S; Li D; Kuang Z; Zhu W; Li Y; Zheng T; Cao W; Zhu B; Tsai E; Fu L; Li M
    Int J Pharm; 2020 Feb; 575():118910. PubMed ID: 31805310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of decomposition of irbesartan in aqueous solutions determined by high performance liquid chromatography.
    Mbah CJ
    Pharmazie; 2004 Dec; 59(12):920-2. PubMed ID: 15638078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method.
    Czerwińska K; Mazurek AP
    Acta Pol Pharm; 2011; 68(6):831-7. PubMed ID: 22125946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine.
    Chang SY; Whigan DB; Vachharajani NN; Patel R
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):149-55. PubMed ID: 9449566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability indicating LC method for simultaneous determination of irbesartan and hydrochlorothiazide in pharmaceutical preparations.
    Rane VP; Patil KR; Sangshetti JN; Yeole RD; Shinde DB
    J Chromatogr Sci; 2010 Aug; 48(7):595-600. PubMed ID: 20819286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-Indicating Liquid Chromatographic Methods with Photodiode Array Detection and Light Scattering Detection for Simultaneous Determination of Candesartan and Hydrochlorothiazide.
    de Diego M; Godoy R; Mennickent S; Vergara C; Miranda D; Navarro P
    J Chromatogr Sci; 2018 Feb; 56(2):99-107. PubMed ID: 29236956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies.
    Tutunji LF; Tutunji MF; Alzoubi MI; Khabbas MH; Arida AI
    J Pharm Biomed Anal; 2010 Mar; 51(4):985-90. PubMed ID: 20004542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated degradation of ibuprofen in tablets.
    Cory WC; Harris C; Martinez S
    Pharm Dev Technol; 2010 Dec; 15(6):636-43. PubMed ID: 19941407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2014 Oct; 474(1-2):80-90. PubMed ID: 25128698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.